Avalo Therapeutics, Inc. (AVTX)
13.65
+0.22
(+1.64%)
USD |
NASDAQ |
Oct 09, 16:00
13.65
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Market Cap : 722.09M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 722.09M |
| October 08, 2026 | 710.46M |
| October 07, 2026 | 718.39M |
| October 06, 2026 | 718.92M |
| October 05, 2026 | 772.35M |
| October 02, 2026 | 792.98M |
| October 01, 2026 | 790.87M |
| September 30, 2026 | 810.97M |
| September 29, 2026 | 824.19M |
| September 28, 2026 | 797.74M |
| September 25, 2026 | 818.37M |
| September 24, 2026 | 831.60M |
| September 23, 2026 | 809.38M |
| September 22, 2026 | 873.39M |
| September 21, 2026 | 855.40M |
| September 18, 2026 | 876.56M |
| September 17, 2026 | 882.91M |
| September 16, 2026 | 877.09M |
| September 15, 2026 | 850.11M |
| September 14, 2026 | 855.93M |
| September 11, 2026 | 852.76M |
| September 10, 2026 | 908.83M |
| September 09, 2026 | 963.32M |
| September 08, 2026 | 1.043B |
| September 04, 2026 | 1.017B |
| Date | Value |
|---|---|
| September 03, 2026 | 1.005B |
| September 02, 2026 | 1.023B |
| September 01, 2026 | 1.002B |
| August 31, 2026 | 1.023B |
| August 28, 2026 | 1.036B |
| August 27, 2026 | 1.061B |
| August 26, 2026 | 1.087B |
| August 25, 2026 | 1.044B |
| August 24, 2026 | 1.019B |
| August 21, 2026 | 1.049B |
| August 20, 2026 | 1.048B |
| August 19, 2026 | 1.098B |
| August 18, 2026 | 1.043B |
| August 17, 2026 | 1.055B |
| August 14, 2026 | 1.036B |
| August 13, 2026 | 1.029B |
| August 12, 2026 | 1.034B |
| August 11, 2026 | 1.030B |
| August 10, 2026 | 1.046B |
| August 07, 2026 | 969.14M |
| August 06, 2026 | 989.24M |
| August 05, 2026 | 996.65M |
| August 04, 2026 | 980.25M |
| August 03, 2026 | 444.71M |
| July 31, 2026 | 449.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 488.54B |
| Rezolute, Inc. | 469.50M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
Market Cap Related Metrics
| PS Ratio | 5565.39 |
| Price to Book Value | 1.609 |
| Price | 13.65 |
| Earnings Yield | -34.72% |